Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06279728
Title Medical Access Program for Datopotamab Deruxtecan in NSCLC Patients
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Daiichi Sankyo
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | CHE | CAN | AUT


No variant requirements are available.